Volume 12, Issue 1 (Jan & Feb 2022)                   J Research Health 2022, 12(1): 33-40 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharifi Nasab M, Yazdimoghaddam H, Mohaddes S T, Rakhshani M H, Abbaszadeh Goudarzi K. The Association Between Diabetes Mellitus With a Five-year Survival Rate of Breast Cancer Patients. J Research Health. 2022; 12 (1) :33-40
URL: http://jrh.gmu.ac.ir/article-1-1998-en.html
1- Department of Nursing, Faculty of Nursing, Sabzevar University of Medical Sciences, Sabzevar, Iran.
2- Iranian Research Center on Healthy Aging, Operating Room Department, Faculty of Paramedics, Sabzevar University of Medical Sciences, Sabzevar, Iran. , ha_yazdimoghaddam@yahoo.com
3- Department of Hematology & Medical Oncology, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
4- Department of Biostatistics and Epidemiology, Iranian Research Center on Health Aging, School of Public Health, Sabzevar University of Medical Sciences, Sabzevar, Iran.
5- Cellular and Molecular Research Center, Faculty of Paramedics, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Abstract:   (348 Views)
Background: Breast cancer is a highly prevalent malignancy leading to death across the world. However, patient survival is greatly affected by making a diabetes diagnosis. The present assessed the association between diabetes mellitus and the five-year survival rate of breast cancer patients at the cancer treatment centers.
Methods: This retrospective follow‐up study was conducted on 534 diabetic women with breast cancer who had been diagnosed during 1999-2013 referring to cancer treatment centers of Mashhad University of Medical Sciences. Demographic and clinical data of patients were collected through questionnaires in these centers searching the patient’s available medical files. Notably, the patients were selected via systematic random sampling, and also the five-year survival of the patients was assessed during the follow-up period up to 2018.
Results: In breast cancer patients, the diabetes prevalence was 12.7%. Of note, the mean and median five-year survival were 9.95 and 13, respectively. No significant difference was observed in the survival rate of the diabetic and non-diabetic patients (95% CI: 0.431-1.334; hazard ratio [HR]: 0.758; P=0.34). The survival time increased in the patients receiving metformin as a treatment protocol (95% CI: 0.226-0.950; HR: 0.5; P=0.04).
Conclusion: Based on the results, training diabetic patients regarding risk factors of breast cancer and effective therapies in controlling hyperglycemia that need to screen in the early diagnosis of breast cancer are essential to improve health and increase survival rate in diabetic patients.
Full-Text [PDF 675 kb]   (80 Downloads) |   |   Full-Text (HTML)  (45 Views)  
Type of Study: Orginal Article | Subject: Health Promotion
Received: 2021/08/26 | Accepted: 2021/12/13 | Published: 2022/02/1

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Research and Health

Designed & Developed by : Yektaweb